| LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
| LINC00052 | miR-193a-3p | ERBB4 | ERBB4；ALS19；HER4；p180erbB4 | details
ErbB signaling pathway；Calcium signaling pathway；Endocytosis；Proteoglycans in cancer
|
details
Collectively, our findings established Linc00152 as a candidate prognostic indicator of outcome and drug responsiveness in colon cancer patients, and the involvement of competing endogenous RNAs mechanism in Linc00152/miR-193a-3p/ERBB4/AKT signaling axis may provide a novel choice in the investigation of drug resistance.
|
details
Linc00152 Functions as a Competing Endogenous RNA to Confer Oxaliplatin Resistance and Holds Prognostic Values in Colon Cancer
|
Colon Cancer | Mol Ther | 27633443 |
| UCA1 | miR-193a-3p | ERBB4 | ERBB4；ALS19；HER4；p180erbB4 | details
ErbB signaling pathway；Calcium signaling pathway；Endocytosis；Proteoglycans in cancer
|
details
Moreover, mechanistic investigations showed that UCA1 upregulated the expression of miR-193a-3p target gene ERBB4 through competitively 'spongeing' miR-193a-3p.
|
details
LncRNA-UCA1 exerts oncogenic functions in non-small cell lung cancer by targeting miR-193a-3p
|
Non-Small Cell Lung Cancer | Cancer Lett | 26655272 |